Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2017

Feb 14, 2018

BUY
$93.56 - $116.6 $84,204 - $104,940
900 Added 300.0%
1,200 $3,000
Q3 2017

Nov 14, 2017

BUY
$109.15 - $138.27 $21,830 - $27,654
200 Added 200.0%
300 $1,000
Q2 2017

Aug 14, 2017

BUY
N/A
100
100 $1,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $18.3B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.